China Resources Double-Crane Pharmaceutical Co.,Ltd.

XSSC:600062 Stock Report

Market Cap: CN¥22.3b

China Resources Double-Crane PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

China Resources Double-Crane PharmaceuticalLtd has a total shareholder equity of CN¥10.9B and total debt of CN¥686.4M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥16.5B and CN¥5.7B respectively. China Resources Double-Crane PharmaceuticalLtd's EBIT is CN¥1.4B making its interest coverage ratio -47.9. It has cash and short-term investments of CN¥2.7B.

Key information

6.3%

Debt to equity ratio

CN¥686.44m

Debt

Interest coverage ratio-47.9x
CashCN¥2.71b
EquityCN¥10.89b
Total liabilitiesCN¥5.66b
Total assetsCN¥16.55b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600062's short term assets (CN¥7.3B) exceed its short term liabilities (CN¥4.6B).

Long Term Liabilities: 600062's short term assets (CN¥7.3B) exceed its long term liabilities (CN¥1.1B).


Debt to Equity History and Analysis

Debt Level: 600062 has more cash than its total debt.

Reducing Debt: 600062's debt to equity ratio has increased from 0.8% to 6.3% over the past 5 years.

Debt Coverage: 600062's debt is well covered by operating cash flow (268%).

Interest Coverage: 600062 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies